Other OTC - Delayed Quote USD

Cresco Labs Inc. (CRLBF)

1.9750 +0.0250 (+1.29%)
As of 11:17 AM EDT. Market Open.
Loading Chart for CRLBF
DELL
  • Previous Close 1.9500
  • Open 2.0000
  • Bid --
  • Ask --
  • Day's Range 1.9500 - 2.0000
  • 52 Week Range 1.0000 - 2.7700
  • Volume 141,345
  • Avg. Volume 928,616
  • Market Cap (intraday) 667.556M
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date May 22, 2024 - May 27, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.88

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

www.crescolabs.com

2,760

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRLBF

Performance Overview: CRLBF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRLBF
45.65%
S&P/TSX Composite index
4.57%

1-Year Return

CRLBF
33.45%
S&P/TSX Composite index
7.22%

3-Year Return

CRLBF
83.13%
S&P/TSX Composite index
14.73%

5-Year Return

CRLBF
84.74%
S&P/TSX Composite index
32.22%

Compare To: CRLBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRLBF

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    659.10M

  • Enterprise Value

    1.24B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    1.31

  • Enterprise Value/Revenue

    1.61

  • Enterprise Value/EBITDA

    -86.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.22%

  • Return on Assets (ttm)

    2.69%

  • Return on Equity (ttm)

    -35.41%

  • Revenue (ttm)

    756.06M

  • Net Income Avi to Common (ttm)

    -175.52M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    103.43M

  • Total Debt/Equity (mrq)

    159.50%

  • Levered Free Cash Flow (ttm)

    20.38M

Research Analysis: CRLBF

Analyst Price Targets

1.25 Low
1.88 Average
1.9750 Current
2.50 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CRLBF

People Also Watch